143 related articles for article (PubMed ID: 23913575)
1. Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results database.
Castillo JJ; Winer ES; Olszewski AJ
Cancer; 2013 Oct; 119(20):3672-9. PubMed ID: 23913575
[TBL] [Abstract][Full Text] [Related]
2. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database.
Castillo JJ; Winer ES; Olszewski AJ
Am J Hematol; 2014 Mar; 89(3):310-4. PubMed ID: 24273125
[TBL] [Abstract][Full Text] [Related]
3. Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database.
Olszewski AJ; Castillo JJ
Cancer; 2013 Feb; 119(3):629-38. PubMed ID: 22893605
[TBL] [Abstract][Full Text] [Related]
4. Trends in survival of patients with stage I/II Burkitt lymphoma in the United States: A SEER database analysis.
Liu ZL; Liu PP; Bi XW; Lei DX; Wang Y; Li ZM; Jiang WQ; Xia Y
Cancer Med; 2019 Mar; 8(3):874-881. PubMed ID: 30706675
[TBL] [Abstract][Full Text] [Related]
5. Gastric Burkitt lymphoma is a distinct subtype that has superior outcomes to other types of Burkitt lymphoma/leukemia.
Park YH; Kim WS; Kang HJ; Na II; Ryoo BY; Yang SH; Lee SS; Uhm JE; Kim K; Jung CW; Park K; Ko YH
Ann Hematol; 2006 May; 85(5):285-90. PubMed ID: 16518604
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina.
Bürgesser MV; Gualco G; Diller A; Natkunam Y; Bacchi CE
Ann Diagn Pathol; 2013 Jun; 17(3):250-5. PubMed ID: 23246412
[TBL] [Abstract][Full Text] [Related]
7. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab.
Gundrum JD; Mathiason MA; Moore DB; Go RS
J Clin Oncol; 2009 Nov; 27(31):5227-32. PubMed ID: 19770371
[TBL] [Abstract][Full Text] [Related]
8. Survival predictors of Burkitt's lymphoma in children, adults and elderly in the United States during 2000-2013.
Mukhtar F; Boffetta P; Risch HA; Park JY; Bubu OM; Womack L; Tran TV; Zgibor JC; Luu HN
Int J Cancer; 2017 Apr; 140(7):1494-1502. PubMed ID: 28006853
[TBL] [Abstract][Full Text] [Related]
9. Ongoing improvement in outcomes for patients diagnosed as having Non-Hodgkin lymphoma from the 1990s to the early 21st century.
Pulte D; Gondos A; Brenner H
Arch Intern Med; 2008 Mar; 168(5):469-76. PubMed ID: 18332290
[TBL] [Abstract][Full Text] [Related]
10. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
11. A Surveillance, Epidemiology, and End Results analysis of small cell carcinoma of the bladder: epidemiology, prognostic variables, and treatment trends.
Koay EJ; Teh BS; Paulino AC; Butler EB
Cancer; 2011 Dec; 117(23):5325-33. PubMed ID: 21567387
[TBL] [Abstract][Full Text] [Related]
12. Population-based analysis of prognostic indicators in sebaceous carcinoma of the head and neck.
Thomas WW; Fritsch VA; Lentsch EJ
Laryngoscope; 2013 Sep; 123(9):2165-9. PubMed ID: 23670399
[TBL] [Abstract][Full Text] [Related]
13. Survival of mycosis fungoides in patients in the Southeast of England.
Morales MM; Putcha V; Evans HS; Olsen J; Llopis A; Møller H
Dermatology; 2005; 211(4):325-9. PubMed ID: 16286740
[TBL] [Abstract][Full Text] [Related]
14. Racial/ethnic differences in survival rates in a population-based series of men with breast carcinoma.
O'Malley CD; Prehn AW; Shema SJ; Glaser SL
Cancer; 2002 Jun; 94(11):2836-43. PubMed ID: 12115370
[TBL] [Abstract][Full Text] [Related]
15. Are survival rates different for young and older patients with rectal cancer?
O'Connell JB; Maggard MA; Liu JH; Etzioni DA; Ko CY
Dis Colon Rectum; 2004 Dec; 47(12):2064-9. PubMed ID: 15657655
[TBL] [Abstract][Full Text] [Related]
16. Inferior prognosis of gastric involvement in patients with gastrointestinal Burkitt Lymphoma.
Xie Y; Jia M; Shi J; Tao Y
Cancer Med; 2020 May; 9(9):3107-3114. PubMed ID: 32160410
[TBL] [Abstract][Full Text] [Related]
17. Primary lymphoma of bone in adult patients.
Jawad MU; Schneiderbauer MM; Min ES; Cheung MC; Koniaris LG; Scully SP
Cancer; 2010 Feb; 116(4):871-9. PubMed ID: 20043324
[TBL] [Abstract][Full Text] [Related]
18. Age, stage, and radiotherapy, but not primary tumor site, affects the outcome of patients with malignant rhabdoid tumors.
Sultan I; Qaddoumi I; Rodríguez-Galindo C; Nassan AA; Ghandour K; Al-Hussaini M
Pediatr Blood Cancer; 2010 Jan; 54(1):35-40. PubMed ID: 19798737
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness and cost of adding rituximab to first-line chemotherapy for elderly patients diagnosed with diffuse large B-cell lymphoma.
Griffiths RI; Gleeson ML; Mikhael J; Dreyling MH; Danese MD
Cancer; 2012 Dec; 118(24):6079-88. PubMed ID: 22648454
[TBL] [Abstract][Full Text] [Related]
20. Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States.
Shenoy PJ; Malik N; Nooka A; Sinha R; Ward KC; Brawley OW; Lipscomb J; Flowers CR
Cancer; 2011 Jun; 117(11):2530-40. PubMed ID: 24048801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
